Form 4 Tracker
Royalty Pharma plc
RPRX

34 insider filings · Latest: Jun 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 19, 2026Mar 19 9:12 PMGeorge Lloyd
Proposed Sale
36,518$45.53$1.7M

View →

Mar 18, 2026Mar 18 10:02 PMGeorge Lloyd
Proposed Sale
100,462$45.79$4.6M

View →

Mar 2, 2026Mar 4 10:11 PMTerrance P. CoyneEVP & CFO
Sale
34,791$46.78$1.6M45,761(I)

View →

Mar 4, 2026Mar 4 9:52 PMGeorge Lloyd
Proposed Sale
136,980$47.43$6.5M

View →

Mar 2, 2026Mar 2 10:26 PMTerrance Coyne
Proposed Sale
34,791$47.47$1.7M

View →

Feb 23, 2026Feb 25 9:08 PMTerrance P. CoyneEVP & CFO
Sale
34,791$45.32$1.6M47,636(I)

View →

Feb 23, 2026Feb 23 10:06 PMTerrance Coyne
Proposed Sale
34,791$45.47$1.6M

View →

Feb 4, 2026Feb 4 10:07 PMTerrance P. CoyneEVP & CFO
Sale
20,163$43.29$872.9K22,885(I)

View →

Feb 3, 2026Feb 4 10:07 PMTerrance P. CoyneEVP & CFO
Sale
114,954$42.84$4.9M23,972(I)

View →

Feb 2, 2026Feb 4 10:07 PMTerrance P. CoyneEVP & CFO
Sale
108,424$42.08$4.6M30,167(I)

View →

Feb 3, 2026Feb 3 10:31 PMTerrance Coyne
Proposed Sale
135,117$42.97$5.8M

View →

Feb 2, 2026Feb 2 10:28 PMTerrance Coyne
Proposed Sale
108,424$42.36$4.6M

View →

Jan 30, 2026Feb 2 9:59 PMMarshall UristEVP, Research & Investments
Sale
20,000$41.09$821.8K0(I)

View →

Jan 23, 2026Jan 26 9:10 PMMarshall UristEVP, Research & Investments
Sale
20,000$40.26$805.1K20,000(I)

View →

Jan 20, 2026Jan 23 9:48 PMTerrance P. CoyneEVP & CFO
Sale
69,582$39.35$2.7M36,010(I)

View →

Jan 16, 2026Jan 20 10:00 PMMarshall UristEVP, Research & Investments
Sale
20,000$39.52$790.3K40,000(I)

View →

Jan 20, 2026Jan 20 9:55 PMTerrance Coyne
Proposed Sale
69,582$39.09$2.7M

View →

Jan 7, 2026Jan 7 10:03 PMGeorge Lloyd
Proposed Sale
495,860$41.39$20.5M

View →

Jan 2, 2026Jan 2 11:22 PMTerrance Coyne
Proposed Sale
69,582$38.86$2.7M

View →

Dec 16, 2025Dec 17 2:41 AMSandy Lamm LLC
Proposed Sale
160,000$38.36$6.1M

View →

Stock Options & Derivatives

No transactions found.